Circio Holding ASA (STU:TA50) Total Tax Payable : €0.00 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Circio Holding ASA Total Tax Payable?

Circio Holding ASA's Total Tax Payable for the quarter that ended in Jun. 2024 was €0.00 Mil.

Circio Holding ASA Total Tax Payable Historical Data

The historical data trend for Circio Holding ASA's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circio Holding ASA Total Tax Payable Chart

Circio Holding ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

Circio Holding ASA Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Tax Payable	Get a 7-Day Free Trial															-	-	-	-	-

Circio Holding ASA Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Circio Holding ASA Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Circio Holding ASA's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Circio Holding ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (STU:TA50) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

CRNA:Norway

Address

Saint Olavs plass, Pb. 6887, Oslo, NOR, 0130

Website

https://www.circio.com

Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients. The company's pipeline candidate includes circVec and Mutant KRAS.

Circio Holding ASA Headlines

No Headlines